|
Volumn 141, Issue 6, 2005, Pages 801-803
|
Déjà vu all over again: Skin cap still contains a high-potency glucocorticosteroid
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIPSORIASIS AGENT;
BETAMETHASONE 21 PROPIONATE;
BETAMETHASONE DERIVATIVE;
CLOBETASOL PROPIONATE;
DERMATOLOGICAL AGENT;
DODECYL SULFATE SODIUM;
PYRITHIONE ZINC;
SKIN CAP;
UNCLASSIFIED DRUG;
CORTICOSTEROID;
CENTRIFUGE;
DRUG CONTAMINATION;
DRUG FORMULATION;
DRUG MARKETING;
DRUG POTENCY;
DRUG SCREENING;
DRUG STRUCTURE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFRARED SPECTROSCOPY;
MASS SPECTROMETRY;
NOTE;
PRIORITY JOURNAL;
PSORIASIS;
RISK ASSESSMENT;
STANDARD;
TANDEM MASS SPECTROMETRY;
CHEMISTRY;
FEMALE;
LETTER;
MALE;
MATERIALS TESTING;
SENSITIVITY AND SPECIFICITY;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
ADRENAL CORTEX HORMONES;
CHEMISTRY, PHARMACEUTICAL;
DERMATOLOGIC AGENTS;
FEMALE;
HUMANS;
MALE;
MATERIALS TESTING;
PSORIASIS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
|
EID: 21844454195
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.141.6.801 Document Type: Note |
Times cited : (7)
|
References (4)
|